Bridged tricyclic carbamoylpyridone compounds and uses thereof
AssigneeGilead Sciences, Inc.
InventorsHang Chu, Ana Z. Gonzalez Buenrostro, Xiaochun Han, Anna E. Hurtley, Lan Jiang, Jiayao Li, Gregg M. Schwarzwalder, Devleena M. Shivakumar, Matthew J. Von Bargen, Qiaoyin Wu, Hong Yang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to compounds, of Formula I Also disclosed are pharmaceutical compositions comprising said compounds and methods of making said compounds. The compounds of the disclosure are useful in treating or preventing human immunodeficiency virus (HIV) infection.
Claims30
A compound, or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:
A pharmaceutical composition comprising a therapeutically effective amount of a compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
A kit comprising a compound selected from the group consisting of:
- or the pharmaceutically acceptable salt thereof, and instructions for use.
A method of treating an HIV infection in a human having the infection, comprising administering to the human a therapeutically effective amount of a compound, or pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:
Dependencies are inferred from the claim text.